Literature for peptidase C19.107: ubiquitin-specific peptidase 32

Summary Alignment Tree Sequences Sequence features Distribution Literature

(Topics flags: K Knockout, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2023
  1. Jiao,D., Chen,Y., Liu,X., Tang,X., Chen,J., Liu,Y., Jiang,C. and Chen,Q. \<br\>Targeting MET endocytosis or degradation to overcome HGF-induced gefitinib resistance in EGFR-sensitive mutant lung adenocarcinoma\<br\>Biochem Biophys Res Commun (2023) 682, 371-380. PubMed  Europe PubMed DOI
  2. Li,C., Gao,Z., Cui,Z., Liu,Z., Bian,Y., Sun,H., Wang,N., He,Z., Li,B., Li,F., Li,Z., Wang,L., Zhang,D., Yang,L., Xu,Z. and Xu,H. \<br\>Deubiquitylation of Rab35 by USP32 promotes the transmission of imatinib resistance by enhancing exosome secretion in gastrointestinal stromal tumours\<br\>Oncogene (2023) 42, 894-910. PubMed  Europe PubMed DOI
  3. Li,J., Bo,Y., Ding,B. and Wang,L. \<br\>Understanding The Regulatory Role of USP32 and SHMT2 in The Progression of Gastric Cancer\<br\>Cell J (2023) 25, 222-228. PubMed  Europe PubMed DOI  PMC  EPMC
  4. Li,S., Song,Y., Wang,K., Liu,G., Dong,X., Yang,F., Chen,G., Cao,C., Zhang,H., Wang,M., Li,Y., Zeng,T., Liu,C. and Li,B. \<br\>USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target\<br\>Cell Death Discov (2023) 9, 338. PubMed  Europe PubMed DOI  PMC  EPMC  V
  5. Zhang,H., Tao,Y., Ding,X., Wang,Y. and Wang,X. \<br\>Roles of the hsa_circ_0013880/USP32/Rap1b axis in the proliferation and apoptosis of acute myeloid leukemia cells\<br\>Acta Biochim Biophys Sin (Shanghai) (2023) 55, 382-393. PubMed  Europe PubMed DOI  PMC  EPMC  K
  6. 2022
  7. Hertel,A., Alves,L.M., Dutz,H., Tascher,G., Bonn,F., Kaulich,M., Dikic,I., Eimer,S., Steinberg,F. and Bremm,A. \<br\>USP32-regulated LAMTOR1 ubiquitination impacts mTORC1 activation and autophagy induction\<br\>Cell Rep (2022) 41, 111653. PubMed  Europe PubMed DOI
  8. 2021
  9. Chandrasekaran,A.P., Kaushal,K., Park,C.H., Kim,K.S. and Ramakrishna,S. \<br\>USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2\<br\>Theranostics (2021) 11, 9752-9771. PubMed  Europe PubMed DOI  PMC  EPMC
  10. 2020
  11. Dou,N., Hu,Q., Li,L., Wu,Q., Li,Y. and Gao,Y. \<br\>USP32 promotes tumorigenesis and chemoresistance in gastric carcinoma via upregulation of SMAD2\<br\>Int J Biol Sci (2020) 16, 1648-1657. PubMed  Europe PubMed DOI  PMC  EPMC  K
  12. 2019
  13. Li,F., Han,H., Sun,Q., Liu,K., Lin,N., Xu,C., Zhao,Z. and Zhao,W. \<br\>USP28 regulates deubiquitination of histone H2A and cell proliferation\<br\>Exp Cell Res (2019) 379, 11-18. PubMed  Europe PubMed DOI  K
  14. 2010
  15. Akhavantabasi,S., Akman,H.B., Sapmaz,A., Keller,J., Petty,E.M. and Erson,A.E. \<br\>USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers\<br\>Mamm Genome (2010) 21, 388-397. PubMed  Europe PubMed DOI
  16. 2003
  17. [YEAR:4-3-2003]Paulding,C.A., Ruvolo,M. and Haber,D.A. \<br\>The Tre2 (USP6) oncogene is a hominoid-specific gene\<br\>Proc Natl Acad Sci U S A (4-3-2003) 100, 2507-2511. PubMed  Europe PubMed DOI  PMC  EPMC